Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Cao, Lu ^a   Zhou, Yanming ^b   Zhai, Beibei ^a   Liao, Jian ^a   Xu, Wen ^a   Zhang, Ruixiu ^a   Li, Jing ^a   Zhang, Yu ^a   Chen, Lei ^a   Qian, Haihua ^a   Wu, Mengchao ^a   Yin, Zhengfeng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CISPLATIN; E1A ASSOCIATED P300 PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; FLUOROURACIL; GEMCITABINE; HERMES ANTIGEN; MITOMYCIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; SORAFENIB; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CARCINOGEN TESTING; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; LIVER TUMOR; METABOLISM; MOUSE MUTANT; MULTICELLULAR SPHEROID; NONOBESE DIABETIC MOUSE; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOGENICITY TESTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 79958271033     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-71     Document Type: Article

References (41)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543. 10.1016/S1470-2045(01)00486-7, 11905707.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485-1491. 10.1200/JCO.2008.20.7753, 2668555, 19224838.
4. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166. 10.1016/j.ccr.2008.01.013, 18242515.
5. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556. 10.1053/j.gastro.2007.04.025, 17570225.
6. Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 2010, 126:2067-2078.
7. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, Fukushima K, Shiina M, Yamagiwa Y, Kondo Y, Inoue J, Kakazu E, Iwasaki T, Kawagishi N, Shimosegawa T, Sugamura K. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Cancer Sci 2010, 101:2145-2155. 10.1111/j.1349-7006.2010.01661.x, 20707805.
8. Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, Chen C, Liu SQ, Wu MC, Wang HY. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 2008, 68:4287-4295. 10.1158/0008-5472.CAN-07-6691, 18519688.
9. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, akiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 2010, 120:3326-3339. 10.1172/JCI42550, 2929722, 20697159.
10. Sell S, Leffert HL. Liver cancer stem cells. J Clin Oncol 2008, 26:2800-2805. 10.1200/JCO.2007.15.5945, 2515096, 18539957.
11. Wu Y, Wu PY. CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 2009, 18:1127-1134. 10.1089/scd.2008.0338, 19409053.
12. Salnikov AV, Kusumawidjaja G, Rausch V, Bruns H, Gross W, Khamidjanov A, Ryschich E, Gebhard MM, Moldenhauer G, Büchler MW, Schemmer P, Herr I. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter. Cancer Lett 2009, 275:185-193. 10.1016/j.canlet.2008.10.015, 19026485.
13. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996, 175:1-13. 10.1006/dbio.1996.0090, 8608856.
14. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha M. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270. 10.1101/gad.1061803, 196056, 12756227.
15. Suzuki A, Oyama K, Fukao K, Nakauchi H, Taniguchi H. Establishment of clonal colony-forming assay system for pancreatic stem/progenitor cells. Cell Transplant 2002, 11:451-453.
16. Bez A, Corsini E, Curti D, Biggiogera M, Colombo A, Nicosia RF, Pagano SF, Parati EA. Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization. Brain Res 2003, 993:18-29. 10.1016/j.brainres.2003.08.061, 14642827.
17. Shi X, Gipp J, Bushman W. Anchorage-independent culture maintains prostate stem cells. Dev Biol 2007, 312:396-406. 10.1016/j.ydbio.2007.09.042, 2234352, 17976567.
18. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks P. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
19. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone M. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511. 10.1158/0008-5472.CAN-05-0626, 15994920.
20. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, Steindler DA. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 2005, 7:967-976. 10.1593/neo.05394, 1502023, 16331882.
21. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65:9328-9337. 10.1158/0008-5472.CAN-05-1343, 16230395.
22. Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J. Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 2007, 34:429-435. 10.1097/MPA.0b013e318033f9f4, 17446842.
23. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors. Cancer Res 2008, 68:4311-4320. 10.1158/0008-5472.CAN-08-0364, 2553722, 18519691.
24. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 2009, 34:1381-1386.
25. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res 2008, 314:2110-2122. 10.1016/j.yexcr.2008.03.008, 2677207, 18423605.
26. Dunsford HA, Sell S. Production of monoclonal antibodies to preneoplastic liver cell populations induced by chemical carcinogens in rats and to transplantable Morris hepatomas. Cancer Res 1989, 49:4887-4893.
27. Strain AJ, Crosby HA, Nijjar S, Kelly DA, Hubscher SG. Human liver-derived stem cells. Semin Liver Dis 2003, 23:373-384.
28. Van Den Heuvel MC, Slooff MJ, Visser L, Muller M, De Jong KP, Poppema S, Gouw AS. Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology 2001, 33:1387-1393. 10.1053/jhep.2001.24453, 11391527.
29. Michelson S, Slate D. Emergence of the drug-resistant phenotype in tumor subpopulations: a hybrid model. J Natl Cancer Inst 1989, 81:1392-1401. 10.1093/jnci/81.18.1392, 2778825.
30. Perryman SV, Sylvester KG. Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. J Cell Mol Med 2006, 10:292-308. 10.1111/j.1582-4934.2006.tb00400.x, 16796800.
31. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251.
32. Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X, Wen L, Yang X. Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods. Vitro Cell Dev Biol Anim 2008, 44:280-289.
33. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902. 10.1038/nrc1232, 14737120.
34. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003, 301:1308-1310. 10.1126/science.301.5638.1308, 12958339.
35. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS, Smith KM, Look AT, Yeger H, Miller FD, Irwin MS, Thiele CJ, Kaplan DR. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007, 67:11234-11243. 10.1158/0008-5472.CAN-07-0718, 18056449.
36. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, Reya T. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005, 6:314-322. 10.1038/ni1164, 15665828.
37. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002, 99:2369-2378. 10.1182/blood.V99.7.2369, 11895769.
38. Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 2007, 20:458-465. 10.1111/j.1600-0749.2007.00410.x, 17935489.
39. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963. 10.1038/nature03659, 15959515.
40. Martinez Arias A, Zecchini V, Brennan K. CSL-independent Notch signaling: a checkpoint in cell fate decisions during development?. Curr Opin Genet Dev 2002, 12:524-533. 10.1016/S0959-437X(02)00336-2, 12200157.
41. Yamamoto N, Yamamoto S, Inagaki F. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J Biol Chem 2001, 276:45031-45040. 10.1074/jbc.M105245200, 11564735.